(Q94815855)
Statements
One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia (English)
Natalie C Edwards
Jacqueline Pesa
Dennis M Meletiche
Luella Engelhart
Ann K Thompson
Jay Sherr